Analyst stock forecast
Iovance Biotherapeutics Forecast: $9.22 Analyst Target
IOVA has a $9.22 target, Buy rating and 9 analysts. As of 2026-08-20.
Direct answer
Iovance Biotherapeutics's average price target is $9.22.
The target implies +15.4% from the recorded current price, and the consensus rating is Buy.
The low target implies -49.9%, the high target implies +75.2%, and the range spans 125.2% of the current price.
Forecast evidence checked August 20, 2026.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.99
- Average price target
- $9.22
- High price target
- $14.00
- Low price target
- $4.00
- Low target gap
- -49.9%
- Target upside
- +15.4%
- High target gap
- +75.2%
- Target range width
- 125.2%
- Consensus rating
- Buy
- Analysts
- 9
- Evidence date
- August 20, 2026
- Valid through
- August 27, 2026
Explore related company data
Read the frequently asked questions.
What is Iovance Biotherapeutics's average price target?
Iovance Biotherapeutics's verified average price target is $9.22. The target range is $4.00 to $14.00.
How far are Iovance Biotherapeutics's low and high targets from the recorded price?
The low target implies -49.9%, while the high target implies +75.2%.
How many analysts are included in Iovance Biotherapeutics's consensus?
The verified consensus includes 9 analysts.
How is Iovance Biotherapeutics's target upside or downside calculated?
The average target of $9.22 is divided by the recorded price of $7.99, then one is subtracted to produce +15.4%. This does not guarantee a future return.
When was Iovance Biotherapeutics's analyst forecast verified?
The data was verified on 2026-08-20. The dataset is valid through 2026-08-27.